Monday, Oct 03, 2022



A feat in medicine: A new Alzheimer's drug offers hope

September 30, 2022 10:38 pm

Pharma research must be accompanied by addressing two other imperatives: Increasing awareness about the disease and making the new medicines accessible to all

New research: Covid-19 increases Alzheimer's risk in older adults

September 15, 2022 8:08 am

The findings indicated that over the one-year period following the infection, older adults in the Covid-19 cohort faced a risk of 0.68%, nearly double that of the non-Covid-19 cohort, which faced a risk of 0.35%.

Alzheimer’s detection now easier at one shot

June 28, 2022 8:26 pm

Using an algorithm able to select texture and subtle structural features in the brain that are affected by Alzheimer’s could really enhance the information we can gain from standard imaging techniques, says Dr Paresh Malhotra of Imperial College, London

Study on genetic risk for Alzheimer's discovers 42 previously-unknown genes linked to the disease

April 06, 2022 3:06 pm

Researchers said that "with multiple triggers, biological pathways and cell types involved in its development", Alzheimer’s disease is "an extremely complex condition".

Alzheimer's drug cited as Medicare premium jumps by $21.60

November 13, 2021 1:21 pm

The issue is turning into a case study of how one pricey medication for a condition afflicting millions of people can swing the needle on government spending and impact household budgets.

Alzheimer’s care amid pandemic: All you need to know

September 20, 2021 6:30 pm

World Alzheimer's Day 2021: Amid pandemic, rapid memory deterioration has been seen among Alzheimer’s patients, as Covid invasion affects the neurological system, say doctors

How exercise may help keep our memory sharp

August 26, 2021 12:58 pm

Irisin, a hormone produced by muscles during exercise, can enter the brain and improve cognition, a new mouse study suggests.

Explained: How an unproven Alzheimer’s drug got approved

July 22, 2021 8:21 am

In announcing its approval in June, the FDA acknowledged there was not sufficient evidence that the drug would help patients. Instead, it said it was greenlighting Aduhelm under a program called “accelerated approval.”

New drug to treat Alzheimer’s disease could cost the government as much as it spends on NASA

June 24, 2021 10:49 am

There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Drug Administration approved it this month. Analysts expect that Medicare and its enrollees, who pay a share of their prescription drug costs, will spend $5.8 billion to $29 billion on the drug in a single year.

Explained: The new drug for Alzheimer's disease

June 09, 2021 11:10 am

USFDA has approved the first new drug for Alzheimer’s disease in two decades. While it raises hope, it’s costly, and not a cure — it seeks to slow progression. Dementia, including Alzheimer’s, affects 1 in 27 Indians above 60 years.